Anti–PD-1-induced bullous pemphigoid in a renal transplant recipient
Ghassan Barnawi, Abby Johanna Kpata, Raghad Aldibane, Sarah Kashkari, Raquel Lazarowitz, Manish Khanna · 2025
Read Anti–PD-1-induced bullous pemphigoid in a renal transplant recipient by Ghassan Barnawi, Abby Johanna Kpata, Raghad Aldibane, Sarah Kashkari, Raquel Lazarowitz, Manish Khanna (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12744001.txt.
Description
Ghassan Barnawi and co-authors report a blistering skin disease triggered by cancer immunotherapy in a kidney transplant patient. The 74-year-old man took anti-PD-1 drugs, first cemiplimab and later pembrolizumab, for returning skin cancers. Drugs of this class are known to spark bullous pemphigoid, where the immune system attacks the skin's base layer.
The disease surfaced nearly two years after his first dose, and four weeks after the second drug restarted. Widespread itching and tense blisters led to biopsy and immune staining, which confirmed the diagnosis. Oral and topical steroids controlled the rash, though it flared whenever doses tapered. The case shows the tightrope of stirring immunity against cancer while shielding a transplanted organ.
Catalog record
| CREATOR | Ghassan Barnawi, Abby Johanna Kpata, Raghad Aldibane, Sarah Kashkari, Raquel Lazarowitz, Manish Khanna |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |